Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 03, 2021 09:19 ET | Source: Monopar Therapeutics Inc.

Monopar公布新候选药物MNPR-202，并与新加坡国立大学签订癌症临床前评估合作协议

伊利诺伊州威尔梅特, June 03, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc.（纳斯达克股票代码：MNPR）是一家临床阶段生物制药公司，主要专注于开发延长癌症患者寿命或提高其生活质量的专有疗法。公司今日宣布，已与新加坡国立大学（NUS）下属新加坡癌症科学研究所（CSI...
June 03, 2021 08:00 ET | Source: Monopar Therapeutics Inc.

Monopar Announces New Drug Candidate, MNPR-202, and Enters into Collaboration Agreement with the National University of Singapore for Preclinical Evaluation in Cancer

WILMETTE, Ill., June 03, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics...
May 26, 2021 09:16 ET | Source: Monopar Therapeutics Inc.; NorthStar Medical Radioisotopes, LLC

Monopar和NorthStar宣布提交保护MNPR-101放射疗法的物质构成专利申请

伊利诺伊州威尔梅特和威斯康星州贝洛伊特, May 26, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc.（纳斯达克股票代码：MNPR）和NorthStar Medical Radioisotopes...
May 26, 2021 08:00 ET | Source: Monopar Therapeutics Inc.; NorthStar Medical Radioisotopes, LLC

Monopar and NorthStar Announce Filing of Composition of Matter Patent Protecting MNPR-101 Radiotherapeutic

WILMETTE, Ill. and BELOIT, Wis., May 26, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional...
May 24, 2021 08:00 ET | Source: Monopar Therapeutics Inc.

Monopar and NorthStar Announce Patent Filing on Promising Radiopharmaceutical Discovery

WILMETTE, Ill. and BELOIT, Wis., May 24, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional...
May 24, 2021 08:00 ET | Source: Monopar Therapeutics Inc.

Monopar和NorthStar宣布就有前途的放射性药物探索提交专利申请

伊利诺伊州威尔米特和威斯康星州贝洛伊特, May 24, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc.（纳斯达克股票代码：MNPR）和NorthStar Medical Radioisotopes...
May 13, 2021 16:42 ET | Source: Monopar Therapeutics Inc.

Monopar Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Updates

First Patient Dosed in Validive® Phase 2b/3 VOICE Clinical TrialCamsirubicin Run-in Clinical Trial Now Planned to Start in 2H 2021Potential Utility Reported for MNPR-101 as Imaging Agent in Cancer...
March 30, 2021 13:35 ET | Source: Monopar Therapeutics Inc.

Monopar的uPA抗体片段放射性示踪剂在临床前研究中显示出对乳腺癌PET成像的潜力

伊利诺伊州维尔梅特, March 31, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc.（Nasdaq：MNPR）是一家临床阶段的生物制药公司，主要专注于开发延长癌症患者寿命或提高其生活质量的专有疗法。该公司今天宣布发表了一项同行评审研究，标题为“对应纤溶酶原激活剂的工程抗体片段用于通过正电子发射断层显像技术对三阴性乳腺癌的快速勾画。”...
March 30, 2021 07:30 ET | Source: Monopar Therapeutics Inc.

Monopar’s uPA Antibody Fragment Radiotracer Shows Potential for PET Imaging of Breast Cancer in Preclinical Study

WILMETTE, Ill., March 30, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics...
March 25, 2021 08:00 ET | Source: Monopar Therapeutics Inc.

Monopar Therapeutics Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Updates

Validive® Phase 2b/3 VOICE Clinical Trial CommencedCamsirubicin Phase 2 Clinical Trial Anticipated to Start in Q2 2021MNPR-101-Conjugate Data Published in European Journal of Cancer WILMETTE,...